| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to Medicine Index—what about sustainability?
|
Heymann, David L
|
|
2017
|
389 |
10066 |
p. 235-237
3 p.
|
artikel
|
| 2 |
A cure for Crohn's disease by 2032
|
The Lancet,
|
|
2017
|
389 |
10066 |
p. 226-
1 p.
|
artikel
|
| 3 |
Another step towards prevention of food allergy
|
Roberts, Graham
|
|
2017
|
389 |
10066 |
p. 230-231
2 p.
|
artikel
|
| 4 |
A strengthening evidence-base for mass deworming, but questions remain
|
Koukounari, Artemis
|
|
2017
|
389 |
10066 |
p. 231-233
3 p.
|
artikel
|
| 5 |
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|
Rittmeyer, Achim
|
|
2017
|
389 |
10066 |
p. 255-265
11 p.
|
artikel
|
| 6 |
Bulgaria attempts to combat discrimination against Roma
|
Thornton, Jacqui
|
|
2017
|
389 |
10066 |
p. 240-241
2 p.
|
artikel
|
| 7 |
Calls for medically safe heroin mount in Canada
|
Webster, Paul C
|
|
2017
|
389 |
10066 |
p. 239-
1 p.
|
artikel
|
| 8 |
Care of non-communicable diseases in emergencies
|
Slama, Slim
|
|
2017
|
389 |
10066 |
p. 326-330
5 p.
|
artikel
|
| 9 |
CEPI—a new global R&D organisation for epidemic preparedness and response
|
Brende, Børge
|
|
2017
|
389 |
10066 |
p. 233-235
3 p.
|
artikel
|
| 10 |
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
|
Vermeire, Séverine
|
|
2017
|
389 |
10066 |
p. 266-275
10 p.
|
artikel
|
| 11 |
Conrad Shawcross: art in search of discovery
|
Harrison, Natalie
|
|
2017
|
389 |
10066 |
p. 245-
1 p.
|
artikel
|
| 12 |
Department of Error
|
|
|
2017
|
389 |
10066 |
p. 254-
1 p.
|
artikel
|
| 13 |
Department of Error
|
|
|
2017
|
389 |
10066 |
p. 254-
1 p.
|
artikel
|
| 14 |
Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis
|
Clarke, Naomi E
|
|
2017
|
389 |
10066 |
p. 287-297
11 p.
|
artikel
|
| 15 |
Filgotinib for Crohn's disease—expanding treatment options
|
Ananthakrishnan, Ashwin N
|
|
2017
|
389 |
10066 |
p. 228-229
2 p.
|
artikel
|
| 16 |
Governance for the future of global health
|
Piot, Peter
|
|
2017
|
389 |
10066 |
p. 243-244
2 p.
|
artikel
|
| 17 |
Guillain-Barré syndrome: surveillance and cost of treatment strategies
|
Buenz, Eric J
|
|
2017
|
389 |
10066 |
p. 253-
1 p.
|
artikel
|
| 18 |
Guillain-Barré syndrome: surveillance and cost of treatment strategies
|
Durrheim, David N
|
|
2017
|
389 |
10066 |
p. 252-253
2 p.
|
artikel
|
| 19 |
Guillain-Barré syndrome: surveillance and cost of treatment strategies – Authors' reply
|
Willison, Hugh J
|
|
2017
|
389 |
10066 |
p. 253-254
2 p.
|
artikel
|
| 20 |
Health policies for migrant children in Europe and Australia
|
Hjern, Anders
|
|
2017
|
389 |
10066 |
p. 249-
1 p.
|
artikel
|
| 21 |
Lung cancer: current therapies and new targeted treatments
|
Hirsch, Fred R
|
|
2017
|
389 |
10066 |
p. 299-311
13 p.
|
artikel
|
| 22 |
Materiality and thread
|
Kneebone, Roger L
|
|
2017
|
389 |
10066 |
p. 246-247
2 p.
|
artikel
|
| 23 |
Neglected tropical diseases: progress towards addressing the chronic pandemic
|
Molyneux, David H
|
|
2017
|
389 |
10066 |
p. 312-325
14 p.
|
artikel
|
| 24 |
Offline: Tackling the despair of England's NHS
|
Horton, Richard
|
|
2017
|
389 |
10066 |
p. 238-
1 p.
|
artikel
|
| 25 |
Opportunities and challenges of a World Serum Bank
|
Coates, Karen M
|
|
2017
|
389 |
10066 |
p. 251-252
2 p.
|
artikel
|
| 26 |
Opportunities and challenges of a World Serum Bank
|
de Lusignan, Simon
|
|
2017
|
389 |
10066 |
p. 250-251
2 p.
|
artikel
|
| 27 |
Opportunities and challenges of a World Serum Bank – Authors' reply
|
Metcalf, C Jessica E
|
|
2017
|
389 |
10066 |
p. 252-
1 p.
|
artikel
|
| 28 |
Programmed death of chemotherapy in non-small-cell lung cancer?
|
Leduc, Charlotte
|
|
2017
|
389 |
10066 |
p. 227-228
2 p.
|
artikel
|
| 29 |
Psychological aid following medical crises in China
|
Chen, Shanquan
|
|
2017
|
389 |
10066 |
p. 250-
1 p.
|
artikel
|
| 30 |
Puffy hand syndrome
|
Vivaldelli, Ester
|
|
2017
|
389 |
10066 |
p. 298-
1 p.
|
artikel
|
| 31 |
Suicide in Indigenous Australians: a “catastrophic crisis”
|
Cousins, Sophie
|
|
2017
|
389 |
10066 |
p. 242-
1 p.
|
artikel
|
| 32 |
The Lancet–CAMS Health Summit 2017: a call for abstracts from China
|
Cao, Xuetao
|
|
2017
|
389 |
10066 |
p. 237-
1 p.
|
artikel
|
| 33 |
Tobacco elimination: an economic and public health imperative
|
The Lancet,
|
|
2017
|
389 |
10066 |
p. 225-
1 p.
|
artikel
|
| 34 |
Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial
|
Natsume, Osamu
|
|
2017
|
389 |
10066 |
p. 276-286
11 p.
|
artikel
|
| 35 |
Wenner Dudley Johnson
|
Watts, Geoff
|
|
2017
|
389 |
10066 |
p. 248-
1 p.
|
artikel
|
| 36 |
What to expect for China's health in the future
|
The Lancet,
|
|
2017
|
389 |
10066 |
p. 226-
1 p.
|
artikel
|
| 37 |
25 years after Intoxicated by My Illness: challenges for medical humanities
|
Rodríguez-Prat, Andrea
|
|
2017
|
389 |
10066 |
p. 249-250
2 p.
|
artikel
|
Tijdschrift beschrijving